Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-18 5:16 pm Purchase | 2022-07-07 | 13G | Annexon, Inc. ANNX | Redmile Group, LLC | 4,891,693 9.900% | 1,662,776 (+51.50%) | Filing History |
| 2022-07-06 5:15 pm Purchase | 2022-07-01 | 13D | MedAvail Holdings, Inc. MDVL | Redmile Group, LLC | 933,483 50.700% | 282,353 (+43.36%) | Filing History |
| 2022-06-27 5:16 pm Purchase | 2022-06-17 | 13G | Scholar Rock Holding Corporation SRRK | Redmile Group, LLC | 5,352,205 9.900% | 1,727,325 (+47.65%) | Filing History |
| 2022-06-15 5:00 pm Unchanged | 2022-06-13 | 13D | Science 37 Holdings, Inc. SNCE | Redmile Group, LLC | 990,412 17.100% | 0 (Unchanged) | Filing History |
| 2022-06-03 5:16 pm Purchase | 2022-05-24 | 13G | RAPT Therapeutics, Inc. RAPT | Redmile Group, LLC | 399,920 9.900% | 399,920 (New Position) | Filing History |
| 2022-05-09 5:15 pm Purchase | 2022-04-29 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Redmile Group, LLC | 5,680,917 8.100% | 5,016,100 (+754.51%) | Filing History |
| 2022-04-06 5:15 pm Purchase | 2022-04-04 | 13D | MedAvail Holdings, Inc. MDVL | Redmile Group, LLC | 651,130 41.800% | 423,529 (+186.08%) | Filing History |
| 2022-04-05 5:09 pm Sale | 2022-04-01 | 13D | IGM Biosciences, Inc. IGMS | Redmile Group, LLC | 3,362,460 12.900% | -75,572 (-2.20%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Akero Therapeutics, Inc. AKRO | Redmile Group, LLC | 1,602,285 4.600% | -720,272 (-31.01%) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Redmile Group, LLC | 28,405,042 9.990% | 6,279,553 (+28.38%) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA | Redmile Group, LLC | 1,472,522 9.900% | 91,445 (+6.62%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Epizyme, Inc. EPZM | Redmile Group, LLC | 3,832,475 3.500% | -6,392,930 (-62.52%) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | ImmunoGen, Inc. IMGN | Redmile Group, LLC | 19,621,981 8.500% | 9,093,802 (+86.38%) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Krystal Biotech, Inc. KRYS | Redmile Group, LLC | 1,820,898 7.300% | 145,862 (+8.71%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | LAVA Therapeutics N.V. LVTX | Redmile Group, LLC | 2,816,196 10.900% | -8,213 (-0.29%) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX | Redmile Group, LLC | 216,078 9.900% | 6,295 (+3.00%) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Replimune Group, Inc. REPL | Redmile Group, LLC | 4,775,461 9.900% | 117,418 (+2.52%) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Scholar Rock Holding Corporation SRRK | Redmile Group, LLC | 3,624,880 9.900% | 212,871 (+6.24%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Stereotaxis, Inc. STXS | Redmile Group, LLC | 7,308,325 9.100% | -525,440 (-6.71%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Stoke Therapeutics, Inc. STOK | Redmile Group, LLC | 2,246,668 6.100% | -439,566 (-16.36%) | Filing History |